Chemical Component Summary

NameN-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine
Identifiers3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzimidazol-5-yl]carbonyl-pyridin-2-yl-amino]propanoic acid
FormulaC25 H25 N7 O3
Molecular Weight471.511
TypeNON-POLYMER
Isomeric SMILES[H]/N=C(\c1ccc(cc1)NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)O)c4ccccn4)/N
InChIInChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)
InChIKeyYBSJFWOBGCMAKL-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count60
Chiral Atom Count0
Bond Count63
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB14726 
NameDabigatran
Groups
  • investigational
  • approved
DescriptionDabigatran is the active form of the orally bioavailable prodrug [dabigatran etexilate].
SynonymsDabigatran
Categories
  • Anticoagulants
  • Antithrombins
  • Benzimidazoles
  • Direct factor Xa inhibitors
  • Enzyme Inhibitors
CAS number211914-51-1

Related Resource References

Resource NameReference
Pharos CHEMBL48361
PubChem 216210, 86309231
ChEMBL CHEMBL48361
ChEBI CHEBI:70752